Farms.com Home   News

Covid-19 Cancels More Farm Shows

Organizers for the Red Deer Agri-Trade Show had been hoping to go ahead with this year's event in November, but have made the decision to cancel the show.
 
David Fiddler, Agri-Trade Expo Show Manager says this has been a difficult decision.
 
"We worked closely with all stakeholders, including Red Deer & District Chamber of Commerce and Westerner Park, to consider all factors.  With travel policies impeding show exhibitors and attendance, we felt that Agri-Trade would not be the show we know it has been since 1984."
 
Meantime, organizers for the 2021 CropSphere Conference in Saskatoon have announced the cancellation of their event.
 
The host organizations deciding to hold a one day virtual conference on January 12th.
 
Each group will hold their Annual General Meetings during the day which will also include market presentations for each crop. 
 
Details on how to register, vote, and submit resolutions will be available in November. 
Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.